Janssen Scientific Affairs, Llc

This program offers a special cell therapy called cilta-cel to people with multiple myeloma who have run out of standard options. The treatment is made from the patient's own immune cells and is given when other therapies are not possible. It is only for those who meet strict saf…

This study looks at the long-term safety of the drug ustekinumab compared to other biologic treatments in adults with Crohn's disease or ulcerative colitis. Researchers will use electronic health records from the Department of Defense to track rates of cancer, serious infections,…